BGLC vs CLOV
BioNexus Gene Lab Corp Common stock (BGLC) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported BGLC revenue for 2024-12-31 was $9.5M. Net income was $1.6M. Revenue was down 2.7% from 2023-12-31 to 2024-12-31. BGLC currently screens at market cap $6.1M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
BGLC currently screens at market cap $6.1M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the BGLC and CLOV stock pages for the full models.
Not investment advice.